Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | MAPT | P10636 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.47 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.47 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21186186 | 0.87 | ALDH1A1 (0.64) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL13415409 | 0.87 | ALDH1A1 (0.64) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL25491800 | 0.87 | ALDH1A1 (0.64) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL10499758 | 0.86 | MAPT (0.50) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL24654488 | 0.84 | CES2 (0.59) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL29763732 | 0.84 | CES2 (0.59) | ALDH1A1MAPTKMT2AHPGDNPC1 | |
| SCHEMBL10499520 | 0.83 | ELANE (0.49) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL21185915 | 0.83 | ALDH1A1 (0.54) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL31054336 | 0.80 | MAPT (0.57) | ALDH1A1MAPTKMT2ALMNAHTT | |
| SCHEMBL10500154 | 0.80 | LMNA (0.46) | ALDH1A1MAPTKMT2ALMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118724773-A | Novel method for preparing thioester by using visible light catalytic sulfonium salt without participation of transition metal | 郑州大学 | 2024-10-01 | — | — | CN | disclosed |
| US-20180052111-A1 | SUBSTRATES, DEVICES, AND METHODS FOR QUANTITATIVE LIQUID CRYSTAL ASSAYS | PLATYPUS TECHNOLOGIES, LLC | 2018-02-22 | — | — | US | disclosed |
| US-9816147-B2 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-11-14 | — | — | US | disclosed |
| US-9816147-B2 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-11-14 | — | — | US | disclosed |
| US-9797843-B2 | Substrates, devices, and methods for quantitative liquid crystal assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-9797843-B2 | Substrates, devices, and methods for quantitative liquid crystal assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-20170212088-A1 | DETECTION OF GAS-PHASE ANALYTES USING LIQUID CRYSTALS | PLATYPUS TECHNOLOGIES, LLC | 2017-07-27 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-9575037-B2 | Detection of gas-phase analytes using liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2017-02-21 | — | — | US | disclosed |
| US-7662572-B2 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-7651662-B2 | Rubbed substrate surfaces; activation; uniform anchoring of liquid crystals | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-01-26 | — | — | US | disclosed |
| US-20100009344-A1 | LIQUID CRYSTAL BASED ANALYTE DETECTION | PLATYPUS TECHNOLOGIES, LLC (US) | 2010-01-14 | — | — | US | disclosed |
| US-7531366-B2 | Bead based assays using a liquid crystal reporter | PLATYPUS TECHNOLOGIES, LLC (US) | 2009-05-12 | — | — | US | disclosed |
| US-20080268546-A1 | DETECTION OF DNA HYBRIDIZATION ON SURFACES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2008-10-30 | — | — | US | disclosed |
| US-20080160539-A1 | Substrates, devices, and methods for cellular assays | PLATYPUS TECHNOLOGIES, LLC (US) | 2008-07-03 | — | — | US | disclosed |
| US-20070178534-A1 | Using liquid crystal support comprising chemotactic and chemokinetic agents to monitor cell migration and invasion; diagnosing cancer | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-08-02 | — | — | US | disclosed |
| US-20070099249-A1 | Compositions and liquid crystals | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-05-03 | — | — | US | disclosed |
| US-20070042505-A1 | Liquid crystal based analyte detection | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-02-22 | — | — | US | disclosed |
| US-20070004046-A1 | Detection of analytes | PLATYPUS TECHNOLOGIES, LLC (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099249-A1 | Compositions and liquid crystals | FABP5, FABP1, SSB | ALDH1A1 4540/4885MAPT 779/4885KMT2A 4615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.